Table 2.
Patient | Sex | Age, y | Type | Location | Genetic Background | Biochemistry | Inhibition at 1μM AZD8055, % | Inhibition at 3μM AZD8055, % |
---|---|---|---|---|---|---|---|---|
1 | F | 44 | P | Right adrenal | Sporadic | NE, DA, NMN | 27.1 | 48.5 (Torin-1, 48.2) |
2 | F | 28 | P | Right adrenal | SDHB | NE, DA, NMN, CgA | 22.6 | 68.9 |
3 | F | 47 | P | Right carotid body | Sporadic | CgA | 23.2 | |
4 | M | 5 | P | Left adrenal | VHL | MN, NMN | 17.1 | 51.9 (Torin-1, 52.4) |
Abbreviations: CgA, chromogranin A; DA, dopamine; F, female; M, male; MN, metanephrine; NE, norepinephrine; NMN, normetanephrine; P, primary.
Included are the percent inhibition with 1 μM and 3 μM AZD8055 and 3 μM Torin-1.